Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part I

Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).

Thrombosis research·2015

The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study.

Journal of thrombosis and thrombolysis·2014

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.

Journal of clinical pharmacology·2014

A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent.

Journal of thrombosis and haemostasis : JTH·2012

Antidote control of aptamer therapeutics: the road to a safer class of drug agents.

Current pharmaceutical biotechnology·2012

Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design.

Journal of thrombosis and thrombolysis·2011

Rural-urban differences for integrated first responder and drone automated external defibrillator delivery in North Carolina.

American heart journal·2026

Accuracy of Indirect Fick Method for Systemic Flow Calculation In Adults With A Fontan Circulation.

American heart journal·2026

Determinants of post-discharge LDL-C testing and target attainment after acute coronary syndrome: a 10-year population-based study.

American heart journal·2026

Incidence, medical therapy, and outcomes in heart failure with improved ejection fraction across guideline definitions.

American heart journal·2026

Clinical and Economic Outcomes in Diagnostic-Naïve Medicare Fee-for-Service Beneficiaries Managed with Alert-Based Ambulatory Cardiac Monitors: the CAMELOT-ALERT Study.

American heart journal·2026

Clinical outcomes associated with recurrent compared to first-time myocardial infarction.

American heart journal·2026

Hypochlorous acid irrigation reduces the rate of infections in patients undergoing implant-based breast reconstruction.

JPRAS open·2026

[A Case of Post-Transplant Lymphoproliferative Disorder with Suspected Thrombosis Leading to Discontinuation of Daprodustat Following Pharmacist Intervention].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Comparative Safety of Common Immunosuppressant Therapies in Systemic Lupus Erythematosus: A Target Trial Emulation Study.

Arthritis & rheumatology (Hoboken, N.J.)·2026

[Detection of anti-Dia antibody in patients with cervical space-occupying lesions following massive blood transfusion].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2026

The Impact of Perioperative Immunosuppression on Post-surgical Outcomes in Patients with Inflammatory Bowel Disease.

Digestive diseases and sciences·2026

Intratumor delivery of a novel plasmid combination induces high levels of metastatic melanoma regression.

Gene therapy·2026

Related Experiment Videos

Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial

Related Concept Videos

Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).

The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study.

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.

A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent.

Antidote control of aptamer therapeutics: the road to a safer class of drug agents.

Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design.

Rural-urban differences for integrated first responder and drone automated external defibrillator delivery in North Carolina.

Accuracy of Indirect Fick Method for Systemic Flow Calculation In Adults With A Fontan Circulation.

Determinants of post-discharge LDL-C testing and target attainment after acute coronary syndrome: a 10-year population-based study.

Incidence, medical therapy, and outcomes in heart failure with improved ejection fraction across guideline definitions.

Clinical and Economic Outcomes in Diagnostic-Naïve Medicare Fee-for-Service Beneficiaries Managed with Alert-Based Ambulatory Cardiac Monitors: the CAMELOT-ALERT Study.

Clinical outcomes associated with recurrent compared to first-time myocardial infarction.

Hypochlorous acid irrigation reduces the rate of infections in patients undergoing implant-based breast reconstruction.

[A Case of Post-Transplant Lymphoproliferative Disorder with Suspected Thrombosis Leading to Discontinuation of Daprodustat Following Pharmacist Intervention].

Comparative Safety of Common Immunosuppressant Therapies in Systemic Lupus Erythematosus: A Target Trial Emulation Study.

[Detection of anti-Dia antibody in patients with cervical space-occupying lesions following massive blood transfusion].

The Impact of Perioperative Immunosuppression on Post-surgical Outcomes in Patients with Inflammatory Bowel Disease.

Intratumor delivery of a novel plasmid combination induces high levels of metastatic melanoma regression.

Related Experiment Videos

Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial...

Related Concept Videos

Related Articles

Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial